Dr Reddys Laboratories Share Price Today - Live Blog for November 07, 2025

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,207.40. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.4700, while the industry's PE ratio is 35.1457.

Dr Reddys Laboratories Ltd witnessed a notable 0.11% surge in its share price and is presently trading at ₹1,207.40, captivating the attention of market participants.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.22% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,207.40 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -0.13% decrease in its share price, and it is currently trading at ₹1,204.40. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.4700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd suffered a -0.26% decline, and it currently trades at ₹1,206.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.11% gain, with the share price now at ₹1,207.55. Notably, the stock's PE ratio stands at 17.4700, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.26%, and as of now, it's trading at ₹1,206.95 per share. This upward trajectory is attracting keen interest from investors.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,203.80. The stock is currently trading at a PE of 17.4700, while the industry PE is 35.1457, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a -0.16% downturn in its share price, and it's currently trading at ₹1,205.65. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd stock price decreased by -0.00%, with the current market value at ₹1,207.85 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.11% recently. As of now, this stock is actively trading at a current market price of ₹1,207.90 per share, attracting attention from investors.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.08% in its share price, and it currently trades at ₹1,206.60 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.08%. At this moment, it's actively trading at ₹1,207.00, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd stock price decreased by -0.28%, with the current market value at ₹1,206.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% decline, and it currently trades at ₹1,209.50 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.12% uptick in its share price. As a result, it's now actively trading at ₹1,209.85 per share, making it an attractive option for investors.

The stock of Dr Reddys Laboratories Ltd is facing a -0.08% decline and is currently trading at ₹1,209.10 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.22% gain, with the share price now at ₹1,211.35. Notably, the stock's PE ratio stands at 17.4700, and its Return on Equity (ROE) is 16.0277%.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,207.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.4700, while the industry's PE ratio is 35.1457.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,207.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.4700, while the industry's PE ratio is 35.1457.

Dr Reddys Laboratories Ltd share price surged by 0.11%. With its current market price standing at ₹1,207.20 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.11% upswing, and it's currently trading at ₹1,205.85 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's shares experienced a 0.34% uptick, and they are currently valued at ₹1,205.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.07%, reaching a current market price of ₹1,200.85. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,201.70, and market participants are assessing the implications. The stock has a PE ratio of 17.4700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.12% increase and currently trading at ₹1,202.00 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.11% upswing, and it's currently trading at ₹1,201.95 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.79% drop, and it's now trading at ₹1,200.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.